Bitwise Crypto Industry Innovators ETF vs Novo Nordisk A/S — how do they compare? Bitwise Crypto Industry Innovators ETF trades at $22.36, while Novo Nordisk A/S trades at $45.94 (market cap $207.85B). The key difference: Novo Nordisk A/S pays a 3.81% dividend while Bitwise Crypto Industry Innovators ETF pays none. Which is the better fit depends on your goals.
| BITQ | NVO | |
|---|---|---|
Sector | Crypto-linked | Health |
52-Week High | $30.43 | $63.98 |
52-Week Low | $16.74 | $35.29 |
Market Cap | — | $207.85B |
Enterprise Value | — | $222.55B |
Dividend Yield | — | 3.81% |
Trailing returns across standard periods
BITQ tracks companies at the forefront of the crypto economy, including miners, equipment suppliers, and financial service providers. It offers indirect exposure to the growth of the broader crypto ecosystem.
Read more on BITQ →With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →